Ovarian Function Following Intraovarian Injection of PRP (NCT04278313) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Ovarian Function Following Intraovarian Injection of PRP
United States90 participantsStarted 2020-02-24
Plain-language summary
Consenting women with evidence of poor ovarian reserve will be randomly assigned to treatment with either Platelet Rich Plasma (PRP) or Platelet Poor Plasma (PPP).
Who can participate
Age range21 Years – 44 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* fewer than 6 oocytes in response to past ovulation induction
* desire to establish a pregnancy using IVF
* Age 44 years and under.
* FSH \> 12
* AMH \< 1.0
* No Aspirin or Motrin for one week before treatment
Exclusion Criteria:
* Age \> 45 years
* Marked thrombocytopenia
* Blood diseases
* Hypofibrinogenemia
* Hemodynamic instability
* Anticoagulant or antiaggregant treatment
* Oncological diseases (specially, skeletal system and blood)
* Sepsis
* Acute and chronic infectious diseases
* Autoimmune diseases, for example, lupus erythematosus, etc.